Bonesupport’s independent distributor network is now promoting CERAMENT bone void filler (BVF) in the US since Zimmer Biomet’s exclusivity period ended on 21 October. According to the latest update, 25 distributors in total had signed up ahead of the previously communicated deadline (end-2018). Other recent news includes Bonesupport’s capital markets days in Stockholm and London, where management presented on CERAMENT products, market opportunities, clinical and economic studies, and new details on the commercial platform. Our valuation is higher at SEK1.49bn or SEK29.0/share (vs SEK22.8/share), upgraded mainly to reflect the substantial expansion of their commercial presence in Europe.
